Metamizol-Mepha 500 mg, Tablette
7680669980023
CH-66998
Tablette
Associated product:
METAMIZOL Mepha cpr 500 mg 50 pce
1 / 3
google
Article details
- Package size
- 50
- Selling units
- 50
- Measure
- Tablette(n)
- Galenic form
- Tablette
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 11.90
Specialties list
Yes
Generic
Yes
SL addition date:
01/12/2019
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 66998
- Drug name
- Metamizol-Mepha, Tablette
- Galenic form
- TAB
- ATC Code
- N02BB02
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 18/12/2018
- Authorization expiration date
- 31/12/9999
- IT Number
- 01.01.1.
- Domain
- Human medicine
Package details
- Description (FR)
- METAMIZOL Mepha cpr 500 mg 50 pce
- Description (DE)
- METAMIZOL Mepha Tabl 500 mg 50 Stk
- Market launch
- 18/12/2018
- Narcotic (BTM)
- No
Original drug
Minalgin, Injektionslösung i.m., i.v.
GTIN: 7680147460641
CHF 13.05
Other package sizes (1)
METAMIZOL Mepha cpr 500 mg 10 pce
10 TABL
GTIN: 7680669980016